first thematic series from Child and Adolescent Psychiatry and Mental
Health features four
articles covering recent developments in the controversial field of pediatric
psychopharmacology. The series on Psychopharmacological
research in paediatric populations links together topics originally
presented at the joint conference of the Berlin Brandenburg Academy of Science and European
Academy held in Berlin earlier this year.
The four articles approach the topic from various
aspects. Benedetto Vitiello’s review highlights recent developments in the field of
pediatric pharmacology research in the USA, while Philippe Auby looks at
the research occurring in the
field in the European Union and Birka Lehmann examines the European Union’s new regulatory
standards for pediatric pharmacology. The series is completed by Jacinta
Tan and Michael Koelch who present the
ethical implications of pediatric pharmacology research and provide
suggestions for improving the ethics of research in this field.
For further information on Psychopharmacological
research in paediatric populations, please read Professor Fegert’s Editorial.